Use of implantable cardioverter-defibrillators in the congenital long QT syndrome.
We surveyed the use of implantable cardioverter-defibrillators in patients with congenital long QT syndrome. The implantable cardioverter-defibrillator was used primarily in high-risk persons and appeared safe and effective over a mean 31-month follow-up.
Groh
W J
WJ
Department of Medicine (Cardiology), Oregon Health Sciences University, Portland 97201-3098, USA.
Silka
M J
MJ
Oliver
R P
RP
Halperin
B D
BD
McAnulty
J H
JH
Kron
J
J
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D017147:Defibrillators, Implantable; D005260:Female; D006801:Humans; D007223:Infant; D008133:Long QT Syndrome / Q000151:congenital / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome